Skip to content

iCBT for Adult Obsessive-Compulsive Disorder

Taking Psychiatry Online: Developing a Platform to Provide Internet-Delivered Cognitive-Behavior Therapy and Testing It in Obsessive-Compulsive Disorder

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07081438
Acronym
icbtadultOCD
Enrollment
25
Registered
2025-07-23
Start date
2025-09-01
Completion date
2027-03-01
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder (OCD)

Keywords

Obsessive-Compulsive Disorder, Cognitive-behavior therapy, icbt, Online treatment, e-health

Brief summary

The goal of the study is to assess the feasibility, acceptability, and potential effects of therapist-guided internet-delivered cognitive-behavior therapy (iCBT) for adult obsessive-compulsive disorder, using a recently developed digital platform.

Detailed description

Although cognitive-behavior therapy (CBT) is a well-established first-line treatment for many mental disorders, very few patients receive it due to the shortage of trained professionals, the costs of face-to-face therapy, and geographic barriers. Therapist-guided internet-delivered CBT (iCBT) is a potential solution to this problem but is not generally available in our context. The investigators plan to: 1. Develop a digital platform for the treatment of mental disorders using therapist-guided iCBT; 2. Assess the feasibility, acceptability, and potential effects of therapist-guided iCBT for adult obsessive-compulsive disorder (OCD) using the platform developed in Objective 1.

Interventions

BEHAVIORALicbt

12-Week Therapist-Based iCBT for OCD (Adapted Version of OCD Net: https://therapistguide.webcbt.se/index.html)

Sponsors

Hospital Clinic of Barcelona
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single-Group Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 75 * Internet access * Principal diagnosis of OCD, based on DSM-5 * Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) Total Severity Score \> 16 * Ability to communicate in Spanish * For participants taking psychotropic medication for OCD: at least eight weeks on stable medication and willingness to stay on the same medication/doses for the 12 weeks of the study

Exclusion criteria

* Estimated IQ \< 70, as per the Vocabulary subtest of the Wechsler Adults Intelligence Scale for Children (WISC) * Eight or more previous sessions of CBT for OCD with an experienced therapist during the last 12 months * Ongoing psychological treatment for OCD * Diagnosis of organic brain disorder, intellectual disability, autism spectrum disorder, psychosis, bipolar disorder, low-weight anorexia nervosa, or alcohol/substance dependence * Immediate risk to self or others (e.g., suicidality) * Inability to communicate in Spanish * Low motivation to participate (i.e., the patient does not believe the therapy will be helpful at all) * Insufficient time to work on the treatment (about 30 minutes per day)

Design outcomes

Primary

MeasureTime frameDescription
Feasibility (recruitment and retention rates and therapist burden)From enrollment to the end of treatment at 12 weeksThe investigators will assess feasibility by recording recruitment rates, retention rates, and therapist burden (time spent by the therapist sending emails, reviewing materials, etc.).

Other

MeasureTime frameDescription
Yale-Brown Obsessive-Compulsive ScaleBaseline and 12 weeksThe Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) evaluates the severity of obsessive-compulsive disorder symptoms in adults. It is a clinician-rated, 10-item scale, with each item rated from 0 (no symptoms) to 4 (extreme symptoms), resulting in a total score ranging from 0 to 40. The scale also provides separate subtotals for the severity of obsessions and compulsions.
Clinical Global Impression (CGI)-SeverityBaseline and 12 weeksThe CGI rates the severity of the patient's illness at the time of assessment on a 7-point scale, from 1 = normal to 7 = among the most extremely ill patients.
Acceptability (Treatment Acceptability/Adherence Scale, TAAS)Immediately after the interventionThe TAAS assesses satisfaction with treatment and adherence.
Negative Effects Questionnaire (NEQ)Baseline, mid-intervention and 12-weeksThe NEQ assesses potential negative side effects of the intervention.
Obsessive-Compulsive Inventory Revised (OCI-R)Baseline and after 12 weeksThe OCI-R assesses obsessive-compulsive symptoms experienced over the past month. It is an 18-item self-report questionnaire covering six symptom dimensions: washing, checking, ordering, obsessing, hoarding, and neutralizing. Each item is rated on a 5-point scale (0 = not at all, 4 = extremely), reflecting the distress caused by the symptom during the past month.
Beck Depression InventoryBaseline and 12 weeksThe BDI assesses the severity of depressive symptoms in adolescents and adults.

Contacts

Primary ContactMiquel A Fullana, PhD
mafullana@clinic.cat34+637908990
Backup ContactMaria Sagué, MD
msague@clinic.cat34 +932 27 54 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026